• Nenhum resultado encontrado

Rev. Bras. Hematol. Hemoter. vol.33 número2

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Bras. Hematol. Hemoter. vol.33 número2"

Copied!
1
0
0

Texto

(1)

Rev Bras Hematol Hemoter. 2011;33(2):167 167

In issue number 1 of the Revista Brasileira de Hematologia e Hemoterapia where the year 2010 is printed at the foot of the page, it should read 2011.

In the memorial lecture of Pedro Clóvis Junqueira the date should read 2010.

On page 4, it should read DOI: 10.5581/1516-8484.20110004

On page 35, it should read DOI: 105581/1516-8484.20110012

The citation of the articles should follow that of the online version of the Revista Brasileira de Hematologia e Hemoterapia at: www.scielo.br/rbhh, www.rbhh.org

Errata

Rev Bras Hematol Hemoter. 2011;33(1)

Referências

Documentos relacionados

The results of aggregation with collagen were considered normal on the first day, with a progressive decrease in platelet function during the five days, when the aggregation

After characterizing the sociodemographic profile of sickle cell disease patients registered in the Rio de Janeiro State Coordinating Blood Bank in the period of 2002-2008,

Results: The prevalence and incidence rates per 100,000 inhabitants in the period of six months were, respectively: acute myeloid leukemia 1.5 and 0.7; acute lymphoblastic leukemia

Several studies have shown that certain combinations of killer immunoglobulin-like receptors and human leukocyte antigens (in both donors and recipients) can affect the chances

Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month

Whole-body positron emission tomography using 18F- fluorodeoxyglucose for post-treatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and

Disease progression after R-CHOP treatment associated with the loss of CD20 antigen expression.. Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo,

Velocardiofacial syndrome patients with a heterozygous chromosome 22q11 deletion have giant platelets. Lazier K, Chow EW, AbdelMalik P, Scutt LE, Weksbergs R,